Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France)

计划入组 30 人 · 首次发布于 2021 年 4 月 22 日

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

首次发布于 2006 年 6 月 12 日

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

计划入组 24 人 · 首次发布于 2016 年 6 月 29 日

PUP-1

Thalidomide inhalation (Vicore Pharma)

Ezetimibe/obicetrapib (NewAmsterdam Pharma)

ABIOGEN PHARMA SPA

Italy

Recordati S.p.A.

Italy

RostaQuo S.p.A.

Ambros Therapeutics Launches with $125M to Advance Non-Opioid Pain Drug Neridronate for Rare Disease CRPS-1

Ambros Therapeutics Secures Key Patent for Precision Medicine Approach to Treating Complex Regional Pain Syndrome

mAbxience Expands European Biosimilar Access Through Strategic Partnerships with Abiogen Pharma and Corapharm